Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 60732 in Healthy Male Volunteers
NCT02244203 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 56
Last updated 2014-09-19
Summary
Single Rising Dose (SRD) study: First evaluation of safety, tolerability, pharmacokinetics and pharmacodynamics of BI 60732
Conditions
- Healthy
Interventions
- DRUG
-
BI 60732
- DRUG
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-02-28
- Primary Completion
- 2009-07-31
More Related Trials
-
A Study in Healthy Men to Test How the Body Takes up and Tolerates Different Doses of BI 765080
NCT04666922 ·Status: COMPLETED ·Phase: PHASE1
-
This Study in Healthy Men Tests How Different Doses of BI 1323495 Are Taken up in the Body and How Well They Are Tolerated.
NCT03588390 ·Status: COMPLETED ·Phase: PHASE1
-
This Study Tests the Safety, Tolerability and How Different Doses of BI 1265162 Are Taken up in the Body of Healthy Men
NCT03349723 ·Status: COMPLETED ·Phase: PHASE1
-
Single Rising Oral Doses of BI 10773 in Healthy Male Volunteers
NCT02182453 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test How Well Men Tolerate Different Doses of BI 3006337
NCT05076422 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 456906 in Healthy Male Volunteers
NCT03175211 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Safety and Tolerability of Single Rising Doses of BI 473494 in Healthy Subjects
NCT03195088 ·Status: TERMINATED ·Phase: PHASE1
-
A Study in Healthy Men to Test How Well Different Doses of BI 1569912 Are Tolerated
NCT04978506 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test How Well Multiple Doses of BI 765423 Are Tolerated by Healthy Men
NCT06232252 ·Status: COMPLETED ·Phase: PHASE1
-
First in Man Trial of BI 113608
NCT01540825 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How Different Doses of BI 1595043 Are Tolerated
NCT04439838 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of BI 113608 in Healthy Asian and Caucasian Male Volunteers
NCT01922349 ·Status: COMPLETED ·Phase: PHASE1
-
To Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 1467335 Following Multiple Dose Administration Over 28 Days
NCT02733627 ·Status: COMPLETED ·Phase: PHASE1
-
This Study is Done in Healthy Japanese Volunteers. It Looks at How Different Doses of BI 730357 Are Taken up in the Body and How Well They Are Tolerated
NCT03793621 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Japanese and Chinese Men to Test How Well Different Doses of BI 706321 Are Tolerated
NCT05183360 ·Status: TERMINATED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 44847 Administered to Healthy Male Subjects
NCT02211924 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How Well Different Doses of BI 1839100 Are Tolerated (1490-0003)
NCT05934955 ·Status: COMPLETED ·Phase: PHASE1
-
To Assess Safety, Tolerability and Pharmacokinetics of BI 443651 in Healthy Male Volunteers
NCT02706925 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test How Different Doses of BI 765423 Are Taken up in the Body of Healthy Men
NCT05658107 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial in Healthy Men and Women to Find Out How Well Different Doses of BI 1291583 Are Tolerated
NCT04866160 ·Status: COMPLETED ·Phase: PHASE1
-
Single Rising Oral Doses of BI 1021958 in Healthy Chinese and Japanese Male Volunteers
NCT01638598 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Japanese Men to Test How Well Different Doses of BI 764198 Are Tolerated
NCT04665700 ·Status: COMPLETED ·Phase: PHASE1
-
This Study is Done in Healthy Japanese Volunteers. It Looks at How Different Doses of BI 1015550 Are Taken up in the Body and How Well They Are Tolerated.
NCT03542344 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of BI 1026706 in Healthy Chinese and Japanese Male Volunteers
NCT02652416 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of BI 409306
NCT01611311 ·Status: COMPLETED ·Phase: PHASE1